» Articles » PMID: 15131017

A Membrane Estrogen Receptor Mediates Intracellular Calcium Release in Astrocytes

Overview
Journal Endocrinology
Specialty Endocrinology
Date 2004 May 8
PMID 15131017
Citations 84
Authors
Affiliations
Soon will be listed here.
Abstract

Appreciating the physiology of astrocytes and their role in brain functions requires an understanding of molecules that activate these cells. Estradiol may influence astrocyte functions. We now report that estrogen altered intracellular calcium concentration ([Ca(2+)](i)) in neonatal astrocytes that expressed estrogen receptor (ER) mRNA in vitro. Western blotting revealed both ERalpha and ERbeta proteins in both the nuclear fractions and plasma-membrane fractions. Application of 17beta-estradiol (20 nm) to fura 2-loaded astrocytes in vitro stimulated [Ca(2+)](i) in 75% of astrocytes with an EC(50) of 12.7 +/- 3.1 nm. This rapid action of estradiol was blocked by the ER antagonist, ICI 182,780. The membrane-impermeable estradiol-BSA induced a [Ca(2+)](i) flux that was statistically similar to estradiol. Removal of extracellular Ca(2+) did not alter the effect of estradiol, but phospholipase C inhibitor U73122 (10 microm) and 2-aminoethoxydiphenyl borate (5 microm), an inhibitor of the inositol-1,4,5,-trisphosphate-gated intracellular Ca(2+) channel, significantly decreased the estradiol-induced [Ca(2+)](i) flux. Estradiol was unable to induce [Ca(2+)](i) flux in thapsigargin-depleted cells. These results indicate that estradiol mediates [Ca(2+)](i) flux in astrocytes through a membrane-associated ER that activates the phospholipase C pathway.

Citing Articles

Astrocytic glutamate transport is essential for the memory-enhancing effects of 17β-estradiol in ovariectomized mice.

Taxier L, Pillerova M, Branyan T, Sohrabji F, Frick K Horm Behav. 2024; 165:105618.

PMID: 39180889 PMC: 11498968. DOI: 10.1016/j.yhbeh.2024.105618.


Expression and function of estrogen receptors and estrogen-related receptors in the brain and their association with Alzheimer's disease.

Sato K, Takayama K, Inoue S Front Endocrinol (Lausanne). 2023; 14:1220150.

PMID: 37469978 PMC: 10352578. DOI: 10.3389/fendo.2023.1220150.


Emerging Evidence on Membrane Estrogen Receptors as Novel Therapeutic Targets for Central Nervous System Pathologies.

Wnuk A, Przepiorska K, Pietrzak B, Kajta M Int J Mol Sci. 2023; 24(4).

PMID: 36835454 PMC: 9968034. DOI: 10.3390/ijms24044043.


Non-genomic Effect of Estradiol on the Neurovascular Unit and Possible Involvement in the Cerebral Vascular Accident.

Goncalves F, Abrantes-Soares F, Pouso M, Lorigo M, Cairrao E Mol Neurobiol. 2023; 60(4):1964-1985.

PMID: 36596967 DOI: 10.1007/s12035-022-03178-7.


Estradiol and Estrogen-like Alternative Therapies in Use: The Importance of the Selective and Non-Classical Actions.

Farkas S, Szabo A, Hegyi A, Torok B, Fazekas C, Ernszt D Biomedicines. 2022; 10(4).

PMID: 35453610 PMC: 9029610. DOI: 10.3390/biomedicines10040861.